ARTL - Artelo Biosciences Inc
1.17
0.030 2.564%
Share volume: 273,235
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$1.14
0.03
0.03%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 03-03-2025 | 05-13-2025 | 08-13-2025 | 11-12-2025 | 02-24-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | ||||
| Operating expenses | 3.812 M | 2.379 M | 3.150 M | 3.089 M | 2.786 M | |
| Selling general and admin | 1.336 M | 995.000 K | 1.279 M | 1.814 M | 1.893 M | |
| Research and development | 2.476 M | 1.384 M | 1.871 M | 1.275 M | 893.000 K | |
| Total expenses | 3.812 M | 2.379 M | 3.150 M | 3.089 M | 2.786 M | |
| -37.59% | 32.41% | -1.94% | -9.81% | |||
| Operating income | -3.812 M | -2.379 M | -3.150 M | -3.089 M | -2.786 M | |
| Ebit | -3.812 M | -2.379 M | -3.150 M | -3.014 M | -2.786 M | |
| Pretax income | -3.778 M | -2.372 M | -3.221 M | -3.120 M | -4.166 M | |
| -37.22% | 35.79% | -3.14% | 33.53% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.778 M | -2.372 M | -3.221 M | -3.120 M | -4.166 M | |
| 37.22% | -35.79% | 3.14% | -33.53% |